Tiangang Li to Liver
This is a "connection" page, showing publications Tiangang Li has written about Liver.
Connection Strength
2.361
-
Combining ASBT inhibitor and FGF15 treatments enhances therapeutic efficacy against cholangiopathy in female but not male Cyp2c70 KO mice. J Lipid Res. 2023 03; 64(3):100340.
Score: 0.695
-
Cullin neddylation inhibitor attenuates hyperglycemia by enhancing hepatic insulin signaling through insulin receptor substrate stabilization. Proc Natl Acad Sci U S A. 2022 02 08; 119(6).
Score: 0.649
-
Gut-restricted apical sodium-dependent bile acid transporter inhibitor attenuates alcohol-induced liver steatosis and injury in mice. Alcohol Clin Exp Res. 2021 06; 45(6):1188-1199.
Score: 0.616
-
Deletion of hepatocyte cysteine dioxygenase type 1, a bile acid repressed gene, enhances glutathione synthesis and ameliorates acetaminophen hepatotoxicity. Biochem Pharmacol. 2024 Apr; 222:116103.
Score: 0.187
-
TFEB regulates sulfur amino acid and coenzyme A metabolism to support hepatic metabolic adaptation and redox homeostasis. Nat Commun. 2022 09 28; 13(1):5696.
Score: 0.170
-
17a-estradiol, a lifespan-extending compound, attenuates liver fibrosis by modulating collagen turnover rates in male mice. Am J Physiol Endocrinol Metab. 2023 02 01; 324(2):E120-E134.
Score: 0.043